IL-2-mediated/JJ
cell/NN
cycle/NN
progression/NN
and/CC
inhibition/NN
of/IN
apoptosis/NN
does/VBZ
not/RB
require/VB
NF-kappa/NN
B/NN
or/CC
activating/VBG
protein-1/NN
activation/NN
in/IN
primary/JJ
human/JJ
T/NN
cells/NNS
./.

The/DT
IL-2/NN
growth/NN
hormone/NN
is/VBZ
the/DT
major/JJ
growth/NN
factor/NN
of/IN
activated/VBN
T/NN
lymphocytes/NNS
during/IN
a/DT
developing/VBG
immune/JJ
response/NN
./.
=====
IL-2/NN
is/VBZ
required/VBN
not/RB
only/RB
for/IN
cell/NN
cycle/NN
progression/NN
but/CC
also/RB
to/TO
protect/VB
Ag-activated/JJ
T/NN
cells/NNS
from/IN
programmed/VBN
cell/NN
death/NN
./.
=====
In/IN
several/JJ
cell/NN
types/NNS
,/,
activation/NN
of/IN
NF-kappa/NN
B/NN
and/or/CC
activating/VBG
protein-1/NN
(/(
AP-1/NN
)/)
has/VBZ
been/VBN
demonstrated/VBN
to/TO
be/VB
extremely/RB
important/JJ
in/IN
blocking/VBG
apoptosis/NN
./.
=====
To/TO
determine/VB
whether/IN
either/DT
or/CC
both/DT
of/IN
these/DT
transcription/NN
factors/NNS
are/VBP
involved/VBN
in/IN
cell/NN
survival/NN
or/CC
cell/NN
cycle/NN
progression/NN
in/IN
response/NN
to/TO
IL-2/NN
,/,
primary/JJ
human/JJ
T/NN
cells/NNS
responsive/JJ
to/TO
the/DT
growth/NN
factor/NN
were/VBD
analyzed/VBN
for/IN
NF-kappa/NN
B/NN
and/CC
AP-1/NN
activation/NN
./.
=====
The/DT
current/JJ
study/NN
clearly/RB
demonstrates/VBZ
that/IN
IL-2/NN
does/VBZ
not/RB
induce/VB
I/NN
kappa/NN
B/NN
alpha/NN
degradation/NN
or/CC
NF-kappa/NN
B/NN
activation/NN
in/IN
primary/JJ
human/JJ
T/NN
cells/NNS
that/WDT
respond/VBP
to/TO
IL-2/NN
by/IN
entering/VBG
the/DT
cell/NN
cycle/NN
and/CC
avoiding/VBG
apoptosis/NN
./.
=====
Similarly/RB
,/,
IL-2/NN
neither/CC
activates/VBZ
JNK/NN
nor/CC
increases/VBZ
AP-1/NN
binding/NN
activity/NN
to/TO
a/DT
consensus/NN
o-tetradecanoylphorbol/NN
13-acetate/NN
(/(
TPA/NN
)/)
response/NN
element/NN
./.
=====
On/IN
the/DT
other/JJ
hand/NN
,/,
the/DT
growth/NN
factor/NN
does/VBZ
induce/VB
the/DT
activation/NN
of/IN
STAT3/NN
and/CC
STAT5/NN
in/IN
these/DT
cells/NNS
,/,
as/IN
has/VBZ
been/VBN
previously/RB
demonstrated/VBN
./.
=====
These/DT
data/NNS
show/VBP
that/IN
neither/CC
NF-kappa/NN
B/NN
nor/CC
AP-1/NN
activation/NN
is/VBZ
required/VBN
for/IN
IL-2-mediated/JJ
survival/NN
or/CC
cell/NN
cycle/NN
progression/NN
in/IN
activated/VBN
primary/JJ
human/JJ
T/NN
cells/NNS
./.